BioSpace News Archive

Dr. Bronner’s Celebrates Historic Victory for Hemp Movement in the U.S.

Today, the Agriculture Improvement Act of 2018 was signed into law.

Ionis Pharmaceuticals, Inc. and its Board of Directors announced today that, effective January 2020, Ionis’ founder and CEO, Stanley T. Crooke, M.D., Ph.D., will be transitioning from chief executive officer to executive chairman of Ionis’ board of directors.

When new safety concerns arise for particular devices, we’re committed to taking action to develop post-market information that can help patients and providers make more informed decisions and also support regulatory actions that reduce any potential risks to patients.

JDRF announced today that it made progressive advances this year on its path to a cure, funding new therapeutic developments to better treat the chronic autoimmune disease affecting 1.25 million Americans.

Safety and efficacy of Essure® have not changed

SV Health Investors, the venture capital and growth equity firm, has promoted Houman Ashrafian to Managing Partner and Greg Madden to Partner.

Cal/OSHA has cited a manufacturer of cannabis products for multiple serious safety violations following an explosion that seriously injured a worker.

EVONETIX LTD (‘Evonetix’), the Cambridge-based company pioneering an innovative approach to scalable and high-fidelity gene synthesis, today announces the formation of its scientific advisory board (SAB). Evonetix has appointed Prof David Klenerman FMedSci FRS and Prof Andrew Briggs to advise the Company on key focus areas in synthetic biology and bioethics, to support the development of its novel DNA synthesis platform.

Geneva Health Solutions (GHS) announced it has been recognized as one of the “Best Entrepreneurial Companies in America” by Entrepreneur magazine’s Entrepreneur 360™ List, a premier study delivering the most comprehensive analysis of private companies in America